Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hypertension"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 407211
Tytuł:
Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension.
Autorzy:
Sykora M; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Szeiffova Bacova B; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Andelova K; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Egan Benova T; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Martiskova A; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Kurahara LH; Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Takamatsu 761-0793, Japan.
Hirano K; Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Takamatsu 761-0793, Japan.
Tribulova N; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 14; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pulmonary Arterial Hypertension*/drug therapy
Hypertension*/drug therapy
Heart Failure*/drug therapy
Humans ; Connexin 43/metabolism ; Arrhythmias, Cardiac/drug therapy ; Arrhythmias, Cardiac/etiology ; Anti-Arrhythmia Agents/pharmacology ; Anti-Arrhythmia Agents/therapeutic use ; Cardiac Conduction System Disease ; Familial Primary Pulmonary Hypertension/complications ; Inflammation/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.
Autorzy:
Wang MT; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.; Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Weng KP; Congenital Structural Heart Disease Center, Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Chang SK; Excelsior Biopharma Inc., Taipei 115, Taiwan.
Huang WC; Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.; Department of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.; Department of Physical Therapy, Fooyin University, Kaohsiung 813, Taiwan.
Chen LW; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.; Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.; Department of Biological Sciences, National Sun Yat-Sen University, Kaohsiung 813, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 27; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/genetics
Humans ; Familial Primary Pulmonary Hypertension/genetics ; Mutation, Missense ; Hemodynamics ; Sequence Deletion ; Bone Morphogenetic Protein Receptors, Type II/genetics ; Mutation ; Adenosine Triphosphatases/genetics ; Membrane Transport Proteins/genetics ; Growth Differentiation Factor 2/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Analysis of genes characterizing chronic thrombosis and associated pathways in chronic thromboembolic pulmonary hypertension.
Autorzy:
Zhan S; Bengbu Medical College, Bengbu, China.
Wang L; Xuzhou Central Hospital, Xuzhou, China.
Wang W; Bengbu Medical College, Bengbu, China.
Li R; Bengbu Medical College, Bengbu, China.; Xuzhou Central Hospital, Xuzhou, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0299912. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Pulmonary*/genetics
Thrombosis*/genetics
Humans ; Familial Primary Pulmonary Hypertension ; Databases, Factual ; Gene Expression Profiling ; Computational Biology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.
Autorzy:
Loponen N; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.
Ylä-Outinen H; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Pulmonary Diseases, Turku University Hospital, Turku, Finland.
Kallionpää RA; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.
Valtanen M; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Mathematics and Statistics, University of Turku, Turku, Finland.; Department of Public Health and Welfare, Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Auranen K; Department of Mathematics and Statistics, University of Turku, Turku, Finland.; Department of Clinical Medicine, University of Turku, Turku, Finland.
Järveläinen H; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Internal Medicine, Satakunta Central Hospital, Pori, Finland.
Peltonen S; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland.; Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Peltonen J; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2024 Jan; Vol. 12 (1), pp. e2346. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Neurofibromatosis 1*/diagnosis
Hypertension*/epidemiology
Male ; Humans ; Female ; Essential Hypertension/epidemiology ; Essential Hypertension/complications ; Risk Factors ; Finland/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies.
Autorzy:
Papavassiliou KA; First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Gogou VA; First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Papavassiliou AG; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 13; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/drug therapy
Humans ; Angiotensin-Converting Enzyme 2/therapeutic use ; Peptidyl-Dipeptidase A/metabolism ; Familial Primary Pulmonary Hypertension ; Receptors, G-Protein-Coupled/metabolism ; Angiotensin I/metabolism ; Peptide Fragments/metabolism ; Renin-Angiotensin System
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study.
Autorzy:
Tsang Y; Real-World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
Stokes M; Data Analytics, Evidera, St-Laurent, Quebec, Canada.
Kim YJ; Data Analytics, Evidera, St-Laurent, Quebec, Canada.
Tilney R; Data Analytics, Evidera, Waltham, Massachusetts, USA.
Panjabi S; Real-World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2023 Dec; Vol. 17 (12), pp. 1209-1222. Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/drug therapy
Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/metabolism
Humans ; Antihypertensive Agents/therapeutic use ; Retrospective Studies ; Familial Primary Pulmonary Hypertension ; Hospitalization ; Disease Progression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pathophysiology and Treatment of Pulmonary Arterial Hypertension.
Autorzy:
Fukumoto Y; Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 18; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Editorial
MeSH Terms:
Pulmonary Arterial Hypertension*/therapy
Hypertension, Pulmonary*/therapy
Humans ; Familial Primary Pulmonary Hypertension
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Relationship between β 1-AA and AT1-AA and Cardiac Function in Patients with Hypertension Complicated with Left Ventricular Diastolic Function Limitation.
Autorzy:
Wang L; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Lv XB; Third Medical Center, The General Hospital of the People's Liberation Army, Beijing 100039, China.
Yuan YT; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Wang N; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Yao HY; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Zhang WC; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Yin PF; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Liu XH; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Pokaż więcej
Źródło:
Cardiovascular therapeutics [Cardiovasc Ther] 2023 Dec 13; Vol. 2023, pp. 7611819. Date of Electronic Publication: 2023 Dec 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/complications
Hypertension*/diagnosis
Hypertension*/drug therapy
Ventricular Dysfunction, Left*/diagnosis
Cardiomyopathies*/complications
Humans ; Autoantibodies ; Ventricular Function, Left ; Essential Hypertension/complications ; Essential Hypertension/diagnosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The relationship of atrial fibrillation with left atrial size in patients with essential hypertension.
Autorzy:
Saadeh R; Department of Public Health and Community Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan. .
Abu Jaber B; Department of Internal Medicine, King Abdullah University Hospital, Irbid, 22110, Jordan.
Alzuqaili T; Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
Ghura S; Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
Al-Ajlouny T; Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
Saadeh AM; Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 13; Vol. 14 (1), pp. 1250. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Atrial Fibrillation*
Coronary Artery Disease*/complications
Hypertension*/complications
Hypertension*/epidemiology
Heart Failure*/complications
Male ; Female ; Humans ; Middle Aged ; Aged ; Stroke Volume ; Retrospective Studies ; Ventricular Function, Left ; Risk Factors ; Essential Hypertension/complications
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Relationship between ambulatory arterial stiffness index and the severity of angiographic atherosclerosis in patients with H-type hypertension and coronary artery disease.
Autorzy:
Dong L; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Liu J; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Qin Y; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Yang WJ; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Nie L; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Liu HN; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Hu QH; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Sun Y; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Cao WY; Department of Three Wards of Cardiovascular Medicine, Anyang Third People's Hospital, Anyang, China.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2228517.
Typ publikacji:
Journal Article
MeSH Terms:
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/diagnostic imaging
Vascular Stiffness*/physiology
Hypertension*/complications
Atherosclerosis*/complications
Humans ; Blood Pressure Monitoring, Ambulatory ; Essential Hypertension/complications
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na excretion and insulin resistance.
Autorzy:
Zhou X; Research Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhang L; Research Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Endocrinology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lin X; Research Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chen X; Research Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Liu H; Research Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yuan X; Health Management Center, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhao Q; Health Management Center, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wang W; Research Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Cardiology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lei X; Research Center for Medicine and Social Development, Collaborative Innovation Center of Social Risks Governance in Health, School of Public Health, Chongqing Medical University, Chongqing, China.
Jose PA; Division of Renal Diseases & Hypertension, Department of Medicine and Department of Physiology and Pharmacology, The George Washington University School of Medicine & Health Sciences, New York, WA, USA.
Deng C; Department of Neurology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yang J; Research Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2276029. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Insulin Resistance*
Hypertension*
Humans ; Ankle Brachial Index ; Pulse Wave Analysis ; Thrombospondins ; Sodium ; Blood Pressure ; Essential Hypertension/complications ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The relationship between circadian rhythm of blood pressure and vascular dysfunction in essential hypertension.
Autorzy:
Sun Y; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Zhang Y; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Liu F; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Liu X; Department of Cardiology, The Liaoyu Hospital of Dalian, Dalian, China.
Hidru TH; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Yang X; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Jiang Y; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2229535.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*
Vascular Stiffness*/physiology
Humans ; Aged ; Blood Pressure ; Ankle Brachial Index ; Blood Pressure Monitoring, Ambulatory ; Cross-Sectional Studies ; Pulse Wave Analysis ; Essential Hypertension/complications ; Circadian Rhythm/physiology ; Dilatation, Pathologic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
Autorzy:
D'Agostino A; IRCCS SYNLAB SDN, Via Emanuele Gianturco 113, 80143 Naples, Italy.
Lanzafame LG; Department of Clinical and Experimental Medicine, Internal Medicine, Garibaldi Hospital, University of Catania, Via Palermo 636, 95122 Catania, Italy.; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Buono L; IRCCS SYNLAB SDN, Via Emanuele Gianturco 113, 80143 Naples, Italy.
Crisci G; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
D'Assante R; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Leone I; IRCCS SYNLAB SDN, Via Emanuele Gianturco 113, 80143 Naples, Italy.
De Vito L; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Bossone E; Department of Public Health, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Cittadini A; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.; Gender Interdipartimental Institute of Research (GENESIS), 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Marra AM; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.; Gender Interdipartimental Institute of Research (GENESIS), 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 19; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pulmonary Arterial Hypertension*/drug therapy
Humans ; Nitric Oxide ; Familial Primary Pulmonary Hypertension ; Phosphodiesterase 5 Inhibitors/pharmacology ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Sildenafil Citrate/pharmacology ; Sildenafil Citrate/therapeutic use ; Soluble Guanylyl Cyclase
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
Autorzy:
Zeng C; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China.
Liu J; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China.
Zheng X; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China.
Hu X; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China. .
He Y; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Nov 01; Vol. 24 (1), pp. 263. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostaglandins*
Pulmonary Arterial Hypertension*/drug therapy
Humans ; Receptors, Prostaglandin ; Vascular Remodeling ; Familial Primary Pulmonary Hypertension ; Epoprostenol/therapeutic use ; Prostaglandins I ; Inflammation/drug therapy ; Pulmonary Artery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective study.
Autorzy:
Perticone M; Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Viale Europa, 88100, Catanzaro, Italy.
Maio R; Geriatric Unit, Azienda Ospedaliero Universitaria R. Dulbecco, Catanzaro, Italy.
Shehaj E; Cardiology and CICU Unit, Giovanni Paolo II Hospital, Lamezia Terme, Catanzaro, Italy.
Gigliotti S; Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Caroleo B; Internal Medicine Unit, Basso Ionio Hospital, Soverato, Catanzaro, Italy.
Suraci E; Internal Medicine Unit, Azienda Ospedaliero Universitaria R. Dulbecco, Catanzaro, Italy.
Sciacqua A; Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Viale Europa, 88100, Catanzaro, Italy.
Andreozzi F; Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Viale Europa, 88100, Catanzaro, Italy.
Perticone F; Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Viale Europa, 88100, Catanzaro, Italy. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Nov 01; Vol. 22 (1), pp. 298. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article
MeSH Terms:
Uric Acid*
Hypertension*
Humans ; Male ; Female ; Prospective Studies ; Risk Factors ; Sex Characteristics ; Essential Hypertension
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding.
Autorzy:
Tomita S; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Nakanishi N; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan. .
Ogata T; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.; Department of Pathology and Cell Regulation, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Higuchi Y; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Sakamoto A; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Tsuji Y; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Suga T; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Matoba S; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Jan 05; Vol. 7 (1), pp. 40. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Caveolin 1*/genetics
Caveolin 1*/metabolism
Hypertension, Pulmonary*
Signal Transduction*
Membrane Proteins*/genetics
Membrane Proteins*/metabolism
RNA-Binding Proteins*/genetics
RNA-Binding Proteins*/metabolism
Animals ; Mice ; Endothelial Cells ; Mice, Knockout ; Pulmonary Arterial Hypertension
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.
Autorzy:
Bassareo PP; Mater Misercordiae University Hospital, D07 R2WY Dublin, Ireland.; Children's Health Ireland at Crumlin, D12 N512 Dublin, Ireland.; School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
D'Alto M; Pulmonary Hypertension Unit, Dipartimento di Cardiologia, Università della Campania 'Luigi Vanvitelli', Ospedale Monaldi, 80131 Naples, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 25; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 25.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Hypertension, Pulmonary*
Pulmonary Arterial Hypertension*
Body Fluids*
Humans ; Metabolomics ; Familial Primary Pulmonary Hypertension
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function-Preclinical Studies.
Autorzy:
Balsa A; Cardiovascular R&D , Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Adão R; Cardiovascular R&D , Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Department of Pharmacology and Toxicology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.; CIBER of Respiratory Diseases (CIBERES), 28029 Madrid, Spain.
Brás-Silva C; Cardiovascular R&D , Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Faculty of Nutrition and Food Sciences, University of Porto, 4150-180 Porto, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 24; Vol. 24 (21). Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pulmonary Arterial Hypertension*/drug therapy
Hypertension, Pulmonary*/drug therapy
Humans ; Mice ; Rats ; Animals ; Ventricular Function, Right ; Pulmonary Artery ; Familial Primary Pulmonary Hypertension ; Disease Models, Animal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
Autorzy:
Qu J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.; Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Li M; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China. .
Zhang X; Department of Rheumatology, Guangdong General Hospital, Guangzhou, China.
Zhang M; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zuo X; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, China.
Zhu P; Department of Clinical Immunology, PLA Specialized Research Institute of Rheumatology and Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Ye S; Department of Rheumatology, School of Medicine, Shanghai Jiao Tong University, Ren Ji Hospital South Campus, Shanghai, China.
Zhang W; Department of Rheumatology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zheng Y; Department of Rheumatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Qi W; Department of Rheumatology, The First Central Hospital, Tianjin, China.
Li Y; Department of Rheumatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhang Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
Ding F; Department of Rheumatology, Qilu Hospital of Shandong University, Jinan, China.
Gu J; Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Liu Y; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Qian J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Huang C; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Zhao J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Wang Q; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Liu Y; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China.
Tian Z; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China.
Wang Y; Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, China Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wei W; Department of Rheumatology, Tianjin Medical University General Hospital, No. 154 Anshan Street, Tianjin, 300052, China. .
Zeng X; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Sep 09; Vol. 24 (1), pp. 220. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/epidemiology
Pulmonary Arterial Hypertension*/etiology
Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/epidemiology
Hypertension, Pulmonary*/etiology
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/epidemiology
Humans ; Cohort Studies ; Prognosis ; Familial Primary Pulmonary Hypertension
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
In the Search for Biomarkers of Pulmonary Arterial Hypertension, Are Cytokines IL-2, IL-4, IL-6, IL-10, and IFN-Gamma the Right Indicators to Use?
Autorzy:
Tomaszewski M; Department of Cardiology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
Mertowska P; Department of Experimental Immunology, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.
Janczewska M; Department of Cardiology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
Styczeń A; Department of Cardiology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
Mertowski S; Department of Experimental Immunology, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.
Jonas K; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Centre for Rare Cardiovascular Diseases, John Paul II Hospital, ul. Pradnicka 80, 31-202 Krakow, Poland.
Grywalska E; Department of Experimental Immunology, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.
Kopeć G; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Centre for Rare Cardiovascular Diseases, John Paul II Hospital, ul. Pradnicka 80, 31-202 Krakow, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 05; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/metabolism
Humans ; Cytokines/metabolism ; Interleukin-10 ; Interleukin-6 ; Interleukin-2 ; Interleukin-4 ; Familial Primary Pulmonary Hypertension ; Interferon-gamma ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 407211

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies